Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Viatris
VTRS
$18.7B
| $57.3M | 0.09% |
2,020,680
-330,248
| -14% | -$9.63M |
|
302
CBRE Group
CBRE
$44B
| $56.8M | 0.09% |
1,148,110
+719,636
| +168% | +$33.8M |
|
303
SEI Investments
SEIC
$13.1B
| $56.8M | 0.09% |
1,086,442
-189,372
| -15% | -$9.48M |
|
304
Analog Devices
ADI
$182B
| $56.6M | 0.08% |
537,862
+219,564
| +69% | +$22M |
|
|
PFPT
305
DELISTED
Proofpoint, Inc.
PFPT
| $56.5M | 0.08% |
465,411
-143,223
| -24% | -$15.7M |
|
306
CALL
AbbVie
ABBV
$468B
| $56.4M | 0.08% |
700,000
+500,000
| +250% | +$40.9M |
|
307
PUT
Micron Technology
MU
$1.09T
| $56.4M | 0.08% |
1,364,200
+335,000
| +33% | +$12.9M |
|
308
Textron
TXT
$14.3B
| $56.3M | 0.08% |
1,112,188
+331,604
| +42% | +$17.1M |
|
309
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $56.1M | 0.08% |
+1,000,000
| New | +$53.5M |
|
310
Wayfair
W
$13.9B
| $55.3M | 0.08% |
+372,667
| New | +$48.6M |
|
311
Steris
STE
$23.2B
| $55.3M | 0.08% |
431,880
-175,594
| -29% | -$20.7M |
|
312
Magnolia Oil & Gas
MGY
$6.67B
| $55.2M | 0.08% |
4,604,047
+1,041,465
| +29% | +$12.7M |
|
313
Public Service Enterprise Group
PEG
$36.2B
| $55.2M | 0.08% |
929,606
-2,223,003
| -71% | -$124M |
|
314
Etsy
ETSY
$7.44B
| $54.9M | 0.08% |
816,186
+101,383
| +14% | +$6.05M |
|
315
Nabors Industries
NBR
$1.37B
| $54.8M | 0.08% |
318,541
+149,539
| +88% | +$23.3M |
|
316
Visteon
VC
$2.83B
| $54.7M | 0.08% |
811,883
+738,508
| +1,006% | +$55.6M |
|
317
Edison International
EIX
$27.5B
| $54.4M | 0.08% |
878,867
+203,980
| +30% | +$12.2M |
|
318
CNX Resources
CNX
$5.38B
| $54.2M | 0.08% |
5,035,378
+721,045
| +17% | +$8.13M |
|
319
Charter Communications
CHTR
$17.9B
| $53.9M | 0.08% |
155,359
+104,678
| +207% | +$34.5M |
|
320
CALL
Broadcom
AVGO
$1.75T
| $53.7M | 0.08% |
1,785,000
+1,415,000
| +382% | +$38.4M |
|
321
Expedia Group
EXPE
$38.6B
| $53.6M | 0.08% |
450,174
-961,038
| -68% | -$117M |
|
322
AstraZeneca
AZN
$257B
| $53M | 0.08% |
655,499
+649,858
| +11,520% | +$51.2M |
|
323
HubSpot
HUBS
$12B
| $53M | 0.08% |
318,653
+134,144
| +73% | +$21.2M |
|
|
EA
324
PUT
DELISTED
Electronic Arts
EA
| $52.9M | 0.08% |
520,900
+198,100
| +61% | +$18.8M |
|
325
Tandem Diabetes Care
TNDM
$1.55B
| $52.8M | 0.08% |
831,625
+177,936
| +27% | +$9.35M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.